4Faneyte IF, Schrama JG, Peterse JL, et al. Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome [J]. Br J Cancer, 2003, 88 (3): 406-412.
5Ogston KN, Miller ID, Schofield AC, et al. Can patients' likelihood of benefiting from primary chemotherapy for breast cancer be predicted before commencement of treatment[J]. Breast Cancer Res Treat, 2004, 86(2):181-189.
6Berry DA, Cirrincione C, Henderson IC, et al. Estrogen receptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer [J]. JAMA, 2006, 295 (14): 1658-1667.
7Susan H, Lee MD, Maureen A, et al. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer[J]. Am J Surg, 2003, 186(4):348-350.
8Piper GL, Patel NA, Malay MB, et al. Neoadjuvant chemotherapy for locally advanced breast cancer results in alterations in preoperative tumor marker status [J]. Am Surg, 2004, 70(12): 1103-1106.
9Macrae M, Neve RM, Rodriguez-Viciana P, et al. A conditional feedback loop regulates Ras activity through EphA2 [J]. Cancer Cell, 2005, 8(2): 111-118.
10Valladares A, Hernandezn G, Gomez FS, et al. Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women [J]. Cancer Genet Cytogene, 2006, 170(2): 147-151.
